ACHN
Achillion Pharmaceuticals
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
110 hedge funds and large institutions have $326M invested in Achillion Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 38 increasing their positions, 33 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
9% less funds holding
Funds holding: 121 → 110 (-11)
50% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 22
Holders
110
Holding in Top 10
1
Calls
$399K
Puts
$75K
Top Buyers
| 1 | +$9.82M | |
| 2 | +$9.07M | |
| 3 | +$7.02M | |
| 4 |
MCO
MAK Capital One
New York
|
+$5.14M |
| 5 |
Goldman Sachs
New York
|
+$5.13M |
Top Sellers
| 1 | -$7.07M | |
| 2 | -$5.33M | |
| 3 | -$2.42M | |
| 4 |
Man Group
London,
United Kingdom
|
-$2.25M |
| 5 |
BlackRock
New York
|
-$1.89M |